GalusMethod OÜ

Active Registry code 16611881 OÜ Registered 11 Nov 2022
Compare

GalusMethod OÜ is a OÜ based in , registry code 16611881, status: active. Main activity: Other human health activities n.e.c.. Its annual report for 2025 shows revenue of €150 and 0 employees.

Revenue
150 €
↓ 91.9% vs 2024
Employees
0
±0 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Human health activities · EMTAK 86

  • Revenue · 2025 150 €
    industry median 20 811 € · companies in the industry: 3 373

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2023 – 2025
Revenue, € 2025: 150 € · −91.9% vs 2024 · industry median 20 811 € · above 18% of the industry
05 00010 00015 00020 00025 0002023 Company: 9 253 € Industry median: 19 480 €20232024 Company: 1 855 € Industry median: 19 998 €20242025 Company: 150 € Industry median: 20 811 €202505 00010 00015 00020 00025 0002023 Company: 9 253 € Industry median: 19 480 €20232024 Company: 1 855 € Industry median: 19 998 €2025 Company: 150 € Industry median: 20 811 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: -784 € · −279.0% vs 2024 · industry median 1 071 € · above 19% of the industry
-2 00002 0004 0006 0002023 Company: 5 845 € Industry median: 1 745 €20232024 Company: 438 € Industry median: 1 625 €20242025 Company: -784 € Industry median: 1 071 €2025-2 00002 0004 0006 0002023 Company: 5 845 € Industry median: 1 745 €20232024 Company: 438 € Industry median: 1 625 €2025 Company: -784 € Industry median: 1 071 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2024: 23.6 % · −39.6 pp vs the year before · industry median 10.7 % · above 69% of the industry
0204060802023 Company: 63.2 % Industry median: 11.5 %20232024 Company: 23.6 % Industry median: 10.7 %20242025 Company: — Industry median: 8.3 %20250204060802023 Company: 63.2 % Industry median: 11.5 %20232024 Company: 23.6 % Industry median: 10.7 %2025 Company: — Industry median: 8.3 %2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 5 499 € · −12.5% vs 2024
02 0004 0006 0008 0002023 Company: 5 845 €20232024 Company: 6 283 €20242025 Company: 5 499 €202502 0004 0006 0008 0002023 Company: 5 845 €20232024 Company: 6 283 €2025 Company: 5 499 €2025
Equity, € 2025: 5 499 € · −12.5% vs 2024
02 0004 0006 0008 0002023 Company: 5 845 €20232024 Company: 6 283 €20242025 Company: 5 499 €202502 0004 0006 0008 0002023 Company: 5 845 €20232024 Company: 6 283 €2025 Company: 5 499 €2025
Employees 2025: 0 · industry median 2 · above 2% of the industry
0.00.51.01.52.02023 Company: 0 Industry median: 220232024 Company: 0 Industry median: 220242025 Company: 0 Industry median: 220250.00.51.01.52.02023 Company: 0 Industry median: 220232024 Company: 0 Industry median: 22025 Company: 0 Industry median: 22025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 150 -784 0 5 499 5 499 0
2024 1 855 438 0 6 283 6 283 0
2023 9 253 5 845 0 5 845 5 845 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
-522.7 %
Net profit / revenue
Return on equity (ROE)
-14.3 %
Net profit / equity
Return on assets (ROA)
-14.3 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets
Debt ratio
0.0 %
Liabilities / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 16 Aug 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 24 Aug 2025 Company’s own e-Äriregister
2023 11 Nov 2022 – 31 Dec 2023 8 Aug 2024 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 86992Other human health activities n.e.c. Main

Rulings 9

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50214916 / 7
5 Dec 2025
 Amendment entry In force
5 Dec 2025
 PDF
Ä 50214916 / M2
27 Nov 2025
 Warning of deletion from the register: contact person not as required 2 Mar 2026 Deficiencies eliminated
5 Dec 2025
 PDF
Ä 50214916 / 6
12 Nov 2025
 Amendment entry In force
12 Nov 2025
 PDF
Ä 50214916 / 5
3 Dec 2024
 Amendment entry In force
3 Dec 2024
 PDF
Ä 50214916 / 4
12 Nov 2024
 Amendment entry In force
12 Nov 2024
 PDF
Ä 50214916 / M1
21 Jul 2024
 Warning of deletion from the register: annual report not filed 24 Oct 2024 Deficiencies eliminated
9 Aug 2024
 PDF
Ä 50214916 / 3
1 Sep 2023
 Amendment entry In force
1 Sep 2023
 PDF
Ä 50214916 / 2
1 Feb 2023
 Amendment entry In force
1 Feb 2023
 PDF
Ä 50214916
11 Nov 2022
 First entry In force
11 Nov 2022
 PDF

Sources: e-Äriregister and EMTA. Data updated 27 Oct 2026. Open at the source ↗ · Report an error in the data